Gilead to raise price for new hepatitis C drug above $84,000

[riky]

Gilead to raise price for new hepatitis C drug above $84,000

By Deena Beasley LOS ANGELES (Reuters) - The next generation version of Gilead Sciences Inc's $84,000 hepatitis C drug, already under fire for its record-breaking costs, is going to be even more expensive. Gregg Alton, Gilead's executive vice president of corporate and medical affairs, declined to give an exact price for the new medicine, the first all-oral treatment for the virus which is expected to launch next month. The total cost of the current treatment is $95,000, which includes Sovaldi and two older medicines, ribavirin and interferon, according to Gilead. The price of the new drug would be based on that cost, Alton said in an interview.

Source: You are not allowed to view links. Register or Login